Cargando…
Therapeutic potential of insulin-like growth factor 2 in Huntington’s disease: controlling proteostasis to alleviate the load of misfolded protein
Autores principales: | Troncoso-Escudero, Paulina, Hetz, Claudio, Vidal, Rene L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323670/ https://www.ncbi.nlm.nih.gov/pubmed/33433484 http://dx.doi.org/10.4103/1673-5374.303020 |
Ejemplares similares
-
Gene therapy in Parkinson's disease: targeting the endplasmic reticulum proteostasis network
por: Castillo, Valentina, et al.
Publicado: (2015) -
Role of Protein Misfolding and Proteostasis Deficiency in Protein Misfolding Diseases and Aging
por: Cuanalo-Contreras, Karina, et al.
Publicado: (2013) -
ER proteostasis disturbances in Parkinson's disease: novel insights
por: Mercado, Gabriela, et al.
Publicado: (2015) -
Small molecules to perform big roles: The search for Parkinson's and Huntington's disease therapeutics
por: Pérez-Arancibia, Rodrigo, et al.
Publicado: (2023) -
On the Right Track to Treat Movement Disorders: Promising Therapeutic Approaches for Parkinson’s and Huntington’s Disease
por: Troncoso-Escudero, Paulina, et al.
Publicado: (2020)